2-cyano-pyrimidines and -triazines as cysteine protease inhibitors

Details for Australian Patent Application No. 2006271946 (hide)

Owner Novartis AG

Inventors Hassiepen, Ulrich; Furet, Pascal; Imbach, Patricia; Zimmermann, Johann; Hommel, Ulrich; Flohr, Stefanie; Litscher, Hans-Ulrich; Gil Parrado, Shirley

Agent Davies Collison Cave

Pub. Number AU-A-2006271946

PCT Pub. Number WO2007/009715

Priority 0514684.0 18.07.05 GB

Filing date 17 July 2006

Wipo publication date 25 January 2007

International Classifications

C07D 239/42 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 31/505 (2006.01) - Pyrimidines

A61P 19/10 (2006.01) Drugs for skeletal disorders

C07D 239/34 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

Event Publications

14 February 2008 PCT application entered the National Phase

  PCT publication WO2007/009715 Priority application(s): WO2007/009715

19 May 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006271947-Preparation of terazole derivatives

2006271933-Breathing mask device and method and mold for producing same